IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJ-D-16-00096

High-risk left main percutaneous coronary intervention supported by pressure-controlled intermittent coronary sinus occlusion

Lorenzo Azzalini, MD, PhD, MSc; Matteo Montorfano, MD; Azeem Latib, MD; Antonio Colombo*, MD

Pressure-controlled intermittent coronary sinus occlusion (PICSO) improves microvascular perfusion in ischaemic areas of the myocardium by intermittently increasing wedge pressure, using a balloon-tipped catheter introduced into the coronary sinus (CS). No experience exists using PICSO to relieve myocardial ischaemia during PCI.

A 75-year-old man with severe left ventricular dysfunction (ejection fraction 25%) and prior mechanical aortic valve replacement presented with heart failure. Critical calcified distal left main (LM) stenosis (Medina 1,1,1) (Panel A) was diagnosed. As coronary bypass surgery was deemed too risky (EuroSCORE 32%), LM PCI under mechanical support was chosen. Severe peripheral vascular disease and mechanical aortic valve prosthesis contraindicated intra-aortic balloon-pump and Impella® (Abiomed, Danvers, MA, USA) use. Therefore, the PICSO® Impulse System (Miracor Medical Systems, Vienna, Austria) (Panel B) was used. The PICSO balloon was delivered into the CS through the right femoral vein, and was left in place (intermittently occluding the CS) throughout the procedure (Panel C). Rotational atherectomy on the LM-circumflex and culotte stenting with two drug-eluting stents were performed. PICSO activity increased during and immediately after rotational atherectomy, thus leading to increased CS pressure (Panel D). CS pressure (a surrogate of coronary flow) improved after stenting (Panel E). The final result was optimal (Panel F). The patient remained stable throughout the procedure and no complication occurred. PICSO quantity was 816 mmHg (values >800 mmHg have been associated with increased myocardial salvage in primary PCI). Peak troponin T was 144 ng/l (normal values: <14 ng/l). The hospital stay was uneventful. This case suggests the feasibility and safety of PICSO as microcirculatory support during high-risk PCI.

Conflict of interest statement

A. Colombo serves as a member of the scientific advisory council of Miracor Medical Systems. The other authors have no conflicts of interest to declare.

Volume 12 Number 11
Dec 9, 2016
Volume 12 Number 11
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV14I12A227 Dec 20, 2018
Amending a dogma
Mohl W et al
free

10.4244/EIJV11I1A3 May 19, 2015
Transcoronary sinus catheter interventions: back in the repertoire?
Mohl W et al
free

10.4244/EIJV17I7A94 Sep 20, 2021
Coronary sinus reducer therapy for refractory angina: is it ready for prime time?
Foley M and Al-Lamee R
free

10.4244/EIJV10STA12 Aug 19, 2014
Shock management in acute myocardial infarction
Poss J et al
free
Trending articles
312.73

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
241.95

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
153.78

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
110.9

Clinical research

10.4244/EIJ-D-20-00130 Oct 9, 2020
Double-kissing culotte technique for coronary bifurcation stenting
Toth GG et al
free
105.53

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
77.75

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
34.75

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
34.4

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved